bpc 157 with kpv FDA panel backs compounded BPC-157, peptides in win for RFK Jr Best Peptides for Gut Health:

NO completed peer-reviewed trials for individual peptides Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite extensive preclinical research on individual peptides, the BPC-157 + TB-500 combination faces substantial translational barriers that severely limit its research utility and prevent any clinical application

It highlights VIPs potential as a therapeutic agent for gastrointestinal disorders, such as irritable bowel syndrome (IBS), due to its ability to modulate muscle activity and reduce inflammation

doi: 10.5681/apb.2013.004

Clarke R, Evans J, Schneede J, Nexo E, Bates C, Fletcher A, et al: Vitamin B12 and folate deficiency in later life